The global Parenteral Packaging market is poised for substantial growth, driven by the rising prevalence of chronic diseases (diabetes, cancer, autoimmune disorders) and the rapid expansion of biologics and biosimilars. Packaging in parenteral is critical for maintaining drug sterility, potency, and therapeutic effectiveness. While the market was valued at approximately USD 15.43 billion in 2024, projections estimate it will reach USD 35–55 billion by 2033-2036, growing at a Compound Annual Growth Rate (CAGR) of 7.1% to 10.8% .
This report refines the market scope by adding critical segments (Material Type, End-User) and key players such as Corning, Amcor, and Stevanato Group. Furthermore, it analyzes the emerging threat of the USA-Israel-Iran conflict, which introduces volatility in raw material supply chains, specifically petroleum-based plastics. The Small Volume Parenteral (SVP) segment continues to dominate due to the surge in prefilled syringes and biologics .
Parenteral packaging refers to the primary containers and closure systems used for drugs administered via injection or infusion. Unlike oral packaging, parenteral packaging must adhere to stringent sterility assurance levels (SAL) and maintain container closure integrity (CCI) to prevent contamination .
The market is evolving from simple glass vials to sophisticated ready-to-mix systems and smart prefilled syringes, driven by the need for self-administration and home healthcare.
Biologics & Biosimilars Boom: Biologics are temperature-sensitive and prone to particulates, demanding high-grade packaging like cyclic olefin polymers (COP) and silicone-free prefilled syringes .
Chronic Disease Epidemic: The rise in cancer and diabetes requires frequent injections, boosting demand for user-friendly parenteral containers .
Raw Material Volatility: Prices of glass (borosilicate) and medical-grade plastic are highly volatile.
Extractables & Leachables (E&L): Strict FDA/EMA regulations require extensive testing for chemical leaching from plastic packaging into the drug, increasing time-to-market .
Smart Packaging: Integration of RFID tags and connectivity for tracking adherence and authenticity .
Hybrid Materials: Companies like SiO2 Materials Science are developing plastic containers with glass barrier coatings, offering break-resistance without compromising drug stability .
Threat of New Entrants (Medium): High capital investment for sterile manufacturing (cleanrooms, isolators) raises entry barriers.
Bargaining Power of Buyers (High): Large pharma companies (Pfizer, J&J) hold significant power over pricing and quality standards.
Bargaining Power of Suppliers (Medium): Specialized glass tubing (e.g., Schott’s FIOLAX®) has few substitutes, but plastic suppliers face more competition.
Threat of Substitutes (Low): There is no substitute for sterile injectable packaging for parenteral drugs.
Industry Rivalry (High): Intense competition between Gerresheimer, Schott, and BD, focusing on innovation in drug delivery systems.
| Strengths | Weaknesses |
|---|---|
| High entry barriers due to regulatory complexity. | High cost of advanced materials vs. standard glass. |
| Essential link in the pharma supply chain. | Environmental concerns regarding single-use plastics. |
| Opportunities | Threats |
| Emerging markets (Asia, Latin America) demand. | Geopolitical instability (Middle East conflict). |
| Growth of gene therapies requiring cold chain packaging. | Strict regulatory changes (USP 1207 for CCI). |
Raw Materials: Mining of silica (glass) vs. petroleum extraction (plastic).
Component Molding/Forming: Conversion into vials, stoppers (West Pharma), or syringes.
Sterilization & Pre-treatment: Depyrogenation and gamma irradiation.
Fill & Finish (Pharma Companies): Drug product filling (the user of the packaging).
Distribution: Cold chain logistics.
Crucial addition to the report.
The escalating tensions involving USA-Israel-Iran introduce a critical supply chain risk for the parenteral packaging market.
Oil Price Shock & Plastic Raw Materials: Most parenteral packaging components (bags, syringe bodies, plastic stoppers) rely on petroleum derivatives. Any military escalation near the Strait of Hormuz (a key oil transit chokepoint) would immediately spike crude oil prices. Impact: Production costs for IV bags and plastic vials would surge, squeezing margins for manufacturers like B. Braun and Fresenius .
Logistics Disruption: Conflict in the Middle East disrupts shipping routes (Red Sea/Suez Canal). This delays the delivery of rubber closures (often sourced from Malaysia/Thailand) and glass tubing to European and American fill-finish sites.
Regional Supply Chain Diversion: As seen in 2023-2024, pharmaceutical companies are now adopting "Just-in-Case" inventory models rather than "Just-in-Time," stockpiling glass vials and stoppers to buffer against war-related shipping delays.
Israel as a Manufacturing Hub: Israel is a hub for generic injectables and pharma innovation. A direct conflict could disrupt local production of parenteral drugs, impacting global supply of critical medications.
Vials: The largest segment by volume, widely used for liquid and lyophilized drugs. Key Player: Schott AG .
Prefilled Syringes & Cartridges: The fastest-growing segment, driven by biologics and self-injection (e.g., Humira, insulin). Key Players: BD, Gerresheimer, Ypsomed .
Ampoules: Declining usage in developed markets due to safety concerns (glass particles) but remains prevalent in generics .
IV Bags: High demand for Large Volume Parenteral (LVP) in hospitals. Key Players: Baxter, Fresenius.
Glass (Type I Borosilicate): Gold standard for stability, inertness, and long shelf life.
Plastic (Polypropylene, COP): Preferred for prefilled syringes due to break-resistance and design flexibility. Key Player: SiO2 Materials Science .
Rubber Closures (Elastomers): Critical for sealing vials and syringes. Key Player: West Pharmaceutical Services .
Small Volume Parenteral (SVP): (<100ml). Dominates market share due to the rise of high-value biologics and vaccines.
Large Volume Parenteral (LVP): (>100ml). Steady growth driven by IV hydration and surgical procedures .
North America (Dominant): Home to major biotech hubs and BD/West Pharma. The US market is driven by demand for advanced delivery systems .
Europe (Mature): Focus on sustainability and glass recycling. German engineering (Schott, Gerresheimer) leads innovation.
Asia-Pacific (Fastest Growing): China and India are manufacturing hubs for low-cost glass vials and ampoules, serving generic drug makers globally.
The market is consolidated among global players who specialize in high-value "Drug Delivery Systems." The report refines the list to include "Active" and influential companies beyond the initial list.
Major Global Manufacturers:
Gerresheimer AG
Specialty: Complex prefilled syringe systems (Glass & Plastic).
Schott AG
Specialty: FIOLAX® glass vials and syringes for biologics.
Becton, Dickinson and Company (BD)
Specialty: Largest manufacturer of medical syringes (Hypak™).
West Pharmaceutical Services, Inc.
Specialty: Elastomeric closures (stoppers) and administration systems (SmartDose®).
Stevanato Group
Specialty: Integrated glass converting and inspector machines (EZ-fill® platform).
Ypsomed AG
Specialty: Pen injectors and auto-injectors (Self-administration).
SiO2 Materials Science
Specialty: Advanced hybrid (Plastic/Glass barrier) syringes.
Corning Incorporated (Valor® Glass)
Specialty: High-speed, damage-resistant pharmaceutical glass tubing.
For Packaging Manufacturers: Diversify raw material suppliers immediately to mitigate risk from the USA-Israel-Iran conflict. Invest in hybrid materials (glass-coated plastic) to offer a "best-of-both-worlds" solution to pharma clients.
For Pharmaceutical Companies (End-Users): Shift from single-sourcing to dual-sourcing for critical components (stoppers, vials). Secure 6-month safety stock for plastic IV bags to weather potential oil-price shocks .
For Investors: Focus on companies with strong Elastomer (Rubber) portfolios (like West Pharma) and High-barrier Plastic technology (like SiO2), as these materials are less susceptible to the extreme price volatility of standard commodities.
The Parenteral Packaging market is on a robust growth trajectory fueled by injectable drug pipelines. However, the industry faces a paradigm shift where geopolitical resilience is as important as technical innovation. The USA-Israel-Iran conflict serves as a stark reminder of the fragility of the petrochemical supply chain. Stakeholders who prioritize supply chain diversification and advanced material science will emerge as market leaders by 2036.
Table of Contents
Global Parenteral Packaging Market Professional Survey Report
1 Industry Overview of Parenteral Packaging
1.1 Definition and Specifications of Parenteral Packaging
1.1.1 Definition of Parenteral Packaging
1.1.2 Specifications of Parenteral Packaging
1.2 Classification of Parenteral Packaging
1.2.1 Bags
1.2.2 Ampoules
1.2.3 Vials
1.2.4 Prefilled syringes & Cartridges
1.2.5 Ready-to-mix Systems
1.3 Applications of Parenteral Packaging
1.3.1 Small Volume Parenteral
1.3.2 Large Volume Parenteral
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Parenteral Packaging
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parenteral Packaging
2.3 Manufacturing Process Analysis of Parenteral Packaging
2.4 Industry Chain Structure of Parenteral Packaging
3 Technical Data and Manufacturing Plants Analysis of Parenteral Packaging
3.1 Capacity and Commercial Production Date of Global Parenteral Packaging Major Manufacturers in
3.2 Manufacturing Plants Distribution of Global Parenteral Packaging Major Manufacturers in
3.3 R&D Status and Technology Source of Global Parenteral Packaging Major Manufacturers in
3.4 Raw Materials Sources Analysis of Global Parenteral Packaging Major Manufacturers in
4 Global Parenteral Packaging Overall Market Overview
4.1 -E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 -E Global Parenteral Packaging Capacity and Growth Rate Analysis
4.2.2 Parenteral Packaging Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 -E Global Parenteral Packaging Sales and Growth Rate Analysis
4.3.2 Parenteral Packaging Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 -E Global Parenteral Packaging Sales Price
4.4.2 Parenteral Packaging Sales Price Analysis (Company Segment)
5 Parenteral Packaging Regional Market Analysis
5.1 North America Parenteral Packaging Market Analysis
5.1.1 North America Parenteral Packaging Market Overview
5.1.2 North America -E Parenteral Packaging Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America -E Parenteral Packaging Sales Price Analysis
5.1.4 North America Parenteral Packaging Market Share Analysis
5.2 Europe Parenteral Packaging Market Analysis
5.2.1 Europe Parenteral Packaging Market Overview
5.2.2 Europe -E Parenteral Packaging Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe -E Parenteral Packaging Sales Price Analysis
5.2.4 Europe Parenteral Packaging Market Share Analysis
5.3 China Parenteral Packaging Market Analysis
5.3.1 China Parenteral Packaging Market Overview
5.3.2 China -E Parenteral Packaging Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China -E Parenteral Packaging Sales Price Analysis
5.3.4 China Parenteral Packaging Market Share Analysis
5.4 Japan Parenteral Packaging Market Analysis
5.4.1 Japan Parenteral Packaging Market Overview
5.4.2 Japan -E Parenteral Packaging Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan -E Parenteral Packaging Sales Price Analysis
5.4.4 Japan Parenteral Packaging Market Share Analysis
5.5 Southeast Asia Parenteral Packaging Market Analysis
5.5.1 Southeast Asia Parenteral Packaging Market Overview
5.5.2 Southeast Asia -E Parenteral Packaging Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia -E Parenteral Packaging Sales Price Analysis
5.5.4 Southeast Asia Parenteral Packaging Market Share Analysis
5.6 India Parenteral Packaging Market Analysis
5.6.1 India Parenteral Packaging Market Overview
5.6.2 India -E Parenteral Packaging Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India -E Parenteral Packaging Sales Price Analysis
5.6.4 India Parenteral Packaging Market Share Analysis
6 Global -E Parenteral Packaging Segment Market Analysis (by Type)
6.1 Global -E Parenteral Packaging Sales by Type
6.2 Different Types of Parenteral Packaging Product Interview Price Analysis
6.3 Different Types of Parenteral Packaging Product Driving Factors Analysis
6.3.1 Bags Growth Driving Factor Analysis
6.3.2 Ampoules Growth Driving Factor Analysis
6.3.3 Vials Growth Driving Factor Analysis
6.3.4 Prefilled syringes & Cartridges Growth Driving Factor Analysis
6.3.5 Ready-to-mix Systems Growth Driving Factor Analysis
7 Global -E Parenteral Packaging Segment Market Analysis (by Application)
7.1 Global -E Parenteral Packaging Consumption by Application
7.2 Different Application of Parenteral Packaging Product Interview Price Analysis
7.3 Different Application of Parenteral Packaging Product Driving Factors Analysis
7.3.1 Small Volume Parenteral of Parenteral Packaging Growth Driving Factor Analysis
7.3.2 Large Volume Parenteral of Parenteral Packaging Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Parenteral Packaging
8.1 Schott
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Schott Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Schott Parenteral Packaging Business Region Distribution Analysis
8.2 Gerresheimer
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Gerresheimer Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Gerresheimer Parenteral Packaging Business Region Distribution Analysis
8.3 Becton
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Becton Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Becton Parenteral Packaging Business Region Distribution Analysis
8.4 Dickinson
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Dickinson Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Dickinson Parenteral Packaging Business Region Distribution Analysis
8.5 Unilife
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Unilife Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Unilife Parenteral Packaging Business Region Distribution Analysis
8.6 West Pharmaceutical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 West Pharmaceutical Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 West Pharmaceutical Parenteral Packaging Business Region Distribution Analysis
8.7 Ypsomed
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Ypsomed Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Ypsomed Parenteral Packaging Business Region Distribution Analysis
8.8 SiO2
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 SiO2 Parenteral Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 SiO2 Parenteral Packaging Business Region Distribution Analysis
9 Development Trend of Analysis of Parenteral Packaging Market
9.1 Global Parenteral Packaging Market Trend Analysis
9.1.1 Global -2025 Parenteral Packaging Market Size (Volume and Value) Forecast
9.1.2 Global -2025 Parenteral Packaging Sales Price Forecast
9.2 Parenteral Packaging Regional Market Trend
9.2.1 North America -2025 Parenteral Packaging Consumption Forecast
9.2.2 Europe -2025 Parenteral Packaging Consumption Forecast
9.2.3 China -2025 Parenteral Packaging Consumption Forecast
9.2.4 Japan -2025 Parenteral Packaging Consumption Forecast
9.2.5 Southeast Asia -2025 Parenteral Packaging Consumption Forecast
9.2.6 India -2025 Parenteral Packaging Consumption Forecast
9.3 Parenteral Packaging Market Trend (Product Type)
9.4 Parenteral Packaging Market Trend (Application)
10 Parenteral Packaging Marketing Type Analysis
10.1 Parenteral Packaging Regional Marketing Type Analysis
10.2 Parenteral Packaging International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Parenteral Packaging by Region
10.4 Parenteral Packaging Supply Chain Analysis
11 Consumers Analysis of Parenteral Packaging
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Parenteral Packaging Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Parenteral Packaging
Table Product Specifications of Parenteral Packaging
Table Classification of Parenteral Packaging
Figure Global Production Market Share of Parenteral Packaging by Type in
Figure Bags Picture
Table Major Manufacturers of Bags
Figure Ampoules Picture
Table Major Manufacturers of Ampoules
Figure Vials Picture
Table Major Manufacturers of Vials
Figure Prefilled syringes & Cartridges Picture
Table Major Manufacturers of Prefilled syringes & Cartridges
Figure Ready-to-mix Systems Picture
Table Major Manufacturers of Ready-to-mix Systems
Table Applications of Parenteral Packaging
Figure Global Consumption Volume Market Share of Parenteral Packaging by Application in
Figure Small Volume Parenteral Examples
Table Major Consumers in Small Volume Parenteral
Figure Large Volume Parenteral Examples
Table Major Consumers in Large Volume Parenteral
Figure Market Share of Parenteral Packaging by Regions
Figure North America Parenteral Packaging Market Size (Million USD) (-2025)
Figure Europe Parenteral Packaging Market Size (Million USD) (-2025)
Figure China Parenteral Packaging Market Size (Million USD) (-2025)
Figure Japan Parenteral Packaging Market Size (Million USD) (-2025)
Figure Southeast Asia Parenteral Packaging Market Size (Million USD) (-2025)
Figure India Parenteral Packaging Market Size (Million USD) (-2025)
Table Parenteral Packaging Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Parenteral Packaging in
Figure Manufacturing Process Analysis of Parenteral Packaging
Figure Industry Chain Structure of Parenteral Packaging
Table Capacity and Commercial Production Date of Global Parenteral Packaging Major Manufacturers in
Table Manufacturing Plants Distribution of Global Parenteral Packaging Major Manufacturers in
Table R&D Status and Technology Source of Global Parenteral Packaging Major Manufacturers in
Table Raw Materials Sources Analysis of Global Parenteral Packaging Major Manufacturers in
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Parenteral Packaging -E
Figure Global -E Parenteral Packaging Market Size (Volume) and Growth Rate
Figure Global -E Parenteral Packaging Market Size (Value) and Growth Rate
Table -E Global Parenteral Packaging Capacity and Growth Rate
Table Global Parenteral Packaging Capacity (K MT) List (Company Segment)
Table -E Global Parenteral Packaging Sales (K MT) and Growth Rate
Table Global Parenteral Packaging Sales (K MT) List (Company Segment)
Table -E Global Parenteral Packaging Sales Price (USD/MT)
Table Global Parenteral Packaging Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Parenteral Packaging -E
Figure North America -E Parenteral Packaging Sales Price (USD/MT)
Figure North America Parenteral Packaging Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Parenteral Packaging -E
Figure Europe -E Parenteral Packaging Sales Price (USD/MT)
Figure Europe Parenteral Packaging Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Parenteral Packaging -E
Figure China -E Parenteral Packaging Sales Price (USD/MT)
Figure China Parenteral Packaging Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Parenteral Packaging -E
Figure Japan -E Parenteral Packaging Sales Price (USD/MT)
Figure Japan Parenteral Packaging Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Parenteral Packaging -E
Figure Southeast Asia -E Parenteral Packaging Sales Price (USD/MT)
Figure Southeast Asia Parenteral Packaging Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Parenteral Packaging -E
Figure India -E Parenteral Packaging Sales Price (USD/MT)
Figure India Parenteral Packaging Sales Market Share
Table Global -E Parenteral Packaging Sales (K MT) by Type
Table Different Types Parenteral Packaging Product Interview Price
Table Global -E Parenteral Packaging Sales (K MT) by Application
Table Different Application Parenteral Packaging Product Interview Price
Table Schott Information List
Table Product Overview
Table Schott Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Schott Parenteral Packaging Business Region Distribution
Table Gerresheimer Information List
Table Product Overview
Table Gerresheimer Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Gerresheimer Parenteral Packaging Business Region Distribution
Table Becton Information List
Table Product Overview
Table Becton Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Becton Parenteral Packaging Business Region Distribution
Table Dickinson Information List
Table Product Overview
Table Dickinson Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Dickinson Parenteral Packaging Business Region Distribution
Table Unilife Information List
Table Product Overview
Table Unilife Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Unilife Parenteral Packaging Business Region Distribution
Table West Pharmaceutical Information List
Table Product Overview
Table West Pharmaceutical Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure West Pharmaceutical Parenteral Packaging Business Region Distribution
Table Ypsomed Information List
Table Product Overview
Table Ypsomed Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Ypsomed Parenteral Packaging Business Region Distribution
Table SiO2 Information List
Table Product Overview
Table SiO2 Parenteral Packaging Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure SiO2 Parenteral Packaging Business Region Distribution
Figure Global -2025 Parenteral Packaging Market Size (K MT) and Growth Rate Forecast
Figure Global -2025 Parenteral Packaging Market Size (Million USD) and Growth Rate Forecast
Figure Global -2025 Parenteral Packaging Sales Price (USD/MT) Forecast
Figure North America -2025 Parenteral Packaging Consumption Volume (K MT) and Growth Rate Forecast
Figure China -2025 Parenteral Packaging Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe -2025 Parenteral Packaging Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia -2025 Parenteral Packaging Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan -2025 Parenteral Packaging Consumption Volume (K MT) and Growth Rate Forecast
Figure India -2025 Parenteral Packaging Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Parenteral Packaging by Type -2025
Table Global Consumption Volume (K MT) of Parenteral Packaging by Application -2025
Table Traders or Distributors with Contact Information of Parenteral Packaging by Region
The market is consolidated among global players who specialize in high-value "Drug Delivery Systems." The report refines the list to include "Active" and influential companies beyond the initial list.
Major Global Manufacturers:
Gerresheimer AG
Specialty: Complex prefilled syringe systems (Glass & Plastic).
Schott AG
Specialty: FIOLAX® glass vials and syringes for biologics.
Becton, Dickinson and Company (BD)
Specialty: Largest manufacturer of medical syringes (Hypak™).
West Pharmaceutical Services, Inc.
Specialty: Elastomeric closures (stoppers) and administration systems (SmartDose®).
Stevanato Group
Specialty: Integrated glass converting and inspector machines (EZ-fill® platform).
Ypsomed AG
Specialty: Pen injectors and auto-injectors (Self-administration).
SiO2 Materials Science
Specialty: Advanced hybrid (Plastic/Glass barrier) syringes.
Corning Incorporated (Valor® Glass)
Specialty: High-speed, damage-resistant pharmaceutical glass tubing.
Upto 24 to 48 hrs (Working Hours)
Upto 72 hrs max (Working Hours) - Weekends and Public Holidays
Single User License - Allows access to only one person to the report.
Multi User License - Allows sharing with max 5 persons within organization.
Corporate License – Can be shared across entire organization.
Online Payments with PayPal
Wire Transfer / Bank Transfer
At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.
ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.
We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.
Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.
Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.